U.S. markets open in 34 minutes

Imagin Medical Inc. (IME.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.40500.0000 (0.00%)
At close: 01:36PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4050
Bid0.3850 x N/A
Ask0.4000 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Avg. Volume9,537
Market Cap3.696M
Beta (5Y Monthly)1.47
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for IME.CN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Imagin Medical Announces Appointment of Kayvon Namvar to Board of Directors and Kevin Slawin, M.D. as Board Chairman

      Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) ("Imagin" or the "Company"), a surgical imaging company visualizing cancer in vital new ways starting with bladder cancer, today reported key changes in the composition of its Board of Directors.

    • PR Newswire

      Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.

      Rapha Capital Management, LLC ("Rapha Capital") today announces it has closed a new convertible note offering totaling US $3 million in three tranches by Rapha Capital BioVentures Fund I, LP ("RCBVFI") to support the clinical development of Imagin Medical Inc.'s (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) ("Imagin" or the "Company") lead product, the i/Blue™ Imaging System. Concurrent with this financing, Kevin Slawin, M.D., a leading urooncologist and manager of the RCBVFI, w

    • GlobeNewswire

      Imagin Medical Secures New $3 Million Convertible Note Financing

      Rapha Capital BioVentures Fund I, LP (RCBVFI) leads new convertible note financing.Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board.Imagin Medical’s i/Blue™ Imaging System is poised to increase patient access to this important technology. VANCOUVER, British Columbia, BOSTON and MIAMI, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announces